$0.02
0.00%
Nasdaq, Wed, Oct 21 2026.
ISIN
US68386J2087
Symbol
OPT

Opthea Limited - ADR Stock price

$0.02
-0.01 36.84% 1M
+0.00 23.08% 6M
+0.00 2.13% YTD
-3.39 99.30% 1Y
-1.66 98.57% 3Y
-7.33 99.67% 5Y
-3.58 99.33% 10Y
-2.86 99.17% 20Y
Nasdaq, Closing price Wed, Oct 21 2026
+0.00 0.00%
ISIN
US68386J2087
Symbol
OPT
Industry

Is Opthea Limited - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
$33.2m
Shares outstanding
1.4b
Valuation
P/E
0.1
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
- | -
P/B
-
Financial Health
Equity Ratio
-354.0%
Return on Equity
81.0%
ROCE
740.2%
ROIC
45,582.9%
Debt/Equity
0.0
Financials
Revenue | estimate
$0.0 | $202.0k
EBITDA
-
EBIT
$249.6m
Net Income
$296.0m
Free Cash Flow | ex SBC
$-123.6m | -
Growth
Revenue | estimate
-100.0% | -3.8%
EBITDA
-
EBIT
208.9%
Net Income
191.0%
Free Cash Flow
39.3%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-8,969,284.9%
Free Cash Flow | ex SBC
- | -
More
EPS
$0.2
FCF per Share
$-0.1
Short interest
0.5%
Employees
33
Rev per Employee
$10.0k

Opthea Limited - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Opthea Limited - ADR forecast:

2x Hold
29%
5x Sell
71%

Analyst Opinions

7 Analysts have issued a Opthea Limited - ADR forecast:

Hold
29%
Sell
71%

Financial data from Opthea Limited - ADR

Dec '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 25 25
18% 18%
-
- Research and Development Expense 83 83
59% 59%
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 250 250
209% 209%
-
Net Profit 296 296
191% 191%
-

In millions USD.

Don't miss a Thing! We will send you all news about Opthea Limited - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Opthea Limited - ADR Stock News

Positive
Proactive Investors
●
one day ago
Cavendish rates Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N), the occupational health provider, a 'buy' with a target price of 302p after a trading update showed the group is on track to meet full year forecasts. The broker says first-half revenue of about £96 million rose 60% year-on-year in the six months to the end of September 2026, helped by the PAM acquisition and continued organic gro...
Positive
Proactive Investors
●
one day ago
Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N), the occupational health and wellbeing services provider, expects first-half revenue to rise 60% to £96 million, reflecting its acquisition of PAM Healthcare and continued growth across its core operations.   The group reported revenue of £59.5 million in the same period a year earlier, while trading for the six months to 30 September remained in ...
Positive
Proactive Investors
●
2 months ago
Cavendish raised its price target on Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N), the occupational health provider, after full-year profit came in ahead of the broker's forecasts and it signalled growing confidence in the company's medium-term targets. The AIM-listed group reported adjusted earnings before interest, tax, depreciation and amortisation of £20.1 million for the year to March, ...
More Opthea Limited - ADR News

Company Profile

Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.

Head office Australia
CEO Frédéric Guerard
Employees 33
Founded 1984
Website opthea.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today